Possible Herd Immunity in the Elderly Following the Vaccination of School Children with Live, Attenuated Trivalent Influenza Vaccine: A Person-Level Analysis

被引:5
|
作者
McBean, Marshall [1 ]
Hull, Harry F. [2 ]
O'Connor, Heidi [1 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA
[2] HF Hull & Assoc, St Paul, MN 55116 USA
关键词
Influenza; Elderly; Children; Herd Immunity; SCHOOLCHILDREN; IMMUNIZATION; IMPACT; MORBIDITY; CAMPAIGN; BURDEN;
D O I
10.1016/j.provac.2011.07.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Models predict that immunizing as few as 20% of school children, important transmitters of influenza, will reduce influenza-related illness in the elderly. We evaluated the potential herd immunity during three influenza seasons, 2005-2006, 2006-2007 and 2007-2008, which followed the immunization of >= 40% of school children in Knox County (KC), TN, with live, attenuated influenza vaccine. Individual-level demographic, health status and health service utilization information about KC residents >= 65 years and those residing in the 8 surrounding counties was obtained from the United States Medicare Program's administrative data. Influenza seasons were identified based on virus isolation. Pneumonia and influenza (P&I) hospitalization rates per 1,000 were compared between the elderly residing in the two areas for the three influenza seasons, and the 3 prior seasons. Differences-in-difference multivariate analysis allowed us to estimate the effect of the school-based immunization program on P&I hospitalization rates simultaneously adjusting for other important individual-level covariates. The age-adjusted rates among the KC residents were significantly lower, 4.62 and 6.02 versus 6.54 and 7.58 than in the residents of the comparison counties during the first two intervention seasons, p = 0.001 and 0.037, respectively, but not in the third. However, after adjusting for the traditionally lower rates of P&I hospitalization in the comparison counties, as well as for the other covariates, we were not able to demonstrate a statistically significant effect of the vaccination program in reducing the rates in either group of the elderly. The impact of the covariates was as expected. Those associated with increased P&I hospitalization rates were increasing age, lower income, poorer health status, prior hospitalization (particularly for P&I), and high prior use of physician services. Influenza immunization of an elderly person reduced his/her probability of being hospitalized for P&I. In conclusion, Immunization of >= 40% of school children did not result in a reduction of P&I hospitalization rates among the elderly. We believe that the failure to show an impact was likely due to the high level of immunization among the elderly (>60%). Administration of influenza vaccine to children as a way to protect the elderly in situations where vaccine supplies are limited or the elderly are not accustomed to receiving influenza vaccine may still be appropriate. (C) 2011 Published by Elsevier Ltd. Selection and peer-review under responsibility of Prof. Ray Spier
引用
收藏
页码:59 / 70
页数:12
相关论文
共 50 条
  • [31] Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study
    Simpson, Colin R.
    Lone, Nazir, I
    Kavanagh, Kim
    Englishby, Tanya
    Robertson, Chris
    McMenamin, Jim
    von Wissman, Beatrix
    Vasileiou, Eleftheria
    Butler, Christopher C.
    Ritchie, Lewis D.
    Gunson, Rory
    Schwarze, Jurgen
    Sheikh, Aziz
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2020, 24 (67) : 1 - +
  • [32] Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia
    Tam, John S.
    Capeding, Maria Rosario Z.
    Lum, Lucy Chai See
    Chotpitayasunondh, Tawee
    Jiang, Zaifang
    Huang, Li-Min
    Lee, Bee Wah
    Qian, Yuan
    Samakoses, Rudiwilai
    Lolekha, Somsak
    Rajamohanan, K. Pillai
    Narayanan, S. Noel
    Kirubakaran, Chellam
    Rappaport, Ruth
    Razmpour, Ahmad
    Gruber, William C.
    Forrest, Bruce D.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (07) : 619 - 628
  • [33] Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres
    Hibbert, Clare L.
    Piedra, Pedro A.
    McLaurin, Kimmie K.
    Vesikari, Timo
    Mauskopf, Josephine
    Mahadevia, Parthiv J.
    [J]. VACCINE, 2007, 25 (47) : 8010 - 8020
  • [34] Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial
    Gaglani, Manjusha J.
    Piedra, Pedro A.
    Riggs, Mark
    Herschler, Gayla
    Fewlass, Charles
    Glezen, W. Paul
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (05) : 444 - 452
  • [35] Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza
    Boikos, Constantina
    Joseph, Lawrence
    Scheifele, David
    Lands, Larry C.
    De Serres, Gaston
    Papenburg, Jesse
    Winters, Nicholas
    Chilvers, Mark
    Quach, Caroline
    [J]. VACCINE, 2017, 35 (37) : 5019 - 5026
  • [36] Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
    Boikos, Constantina
    Joseph, Lawrence
    Martineau, Christine
    Papenburg, Jesse
    Scheifele, David
    Lands, Larry C.
    De Serres, Gaston
    Chilvers, Mark
    Quach, Caroline
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (04):
  • [37] Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Merckx, Joanna
    McCormack, Deirdre
    Quach, Caroline
    [J]. VACCINE, 2016, 34 (06) : 750 - 756
  • [38] Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine
    Martin, Shannon S.
    Bakken, Russell R.
    Lind, Cathleen M.
    Reed, Douglas S.
    Price, Jessica L.
    Koeller, Craig A.
    Parker, Michael D.
    Hart, Mary Kate
    Fine, Donald L.
    [J]. VACCINE, 2009, 27 (49) : 6814 - 6823
  • [39] The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine
    Panapasa, Jack A.
    Cox, Rebecca J.
    Mohn, Kristin G. I.
    Aqrawi, Lara A.
    Brokstad, Karl A.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (07) : 1663 - 1672
  • [40] Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials
    Rhorer, Janelle
    Ambrose, Christopher S.
    Dickinson, Stephanie
    Hamilton, Holli
    Oleka, Napoleon A.
    Malinoski, FrankJ.
    Wittes, Janet
    [J]. VACCINE, 2009, 27 (07) : 1101 - 1110